Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater.

Trial Profile

Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 30 Jun 2015

At a glance

  • Drugs Linezolid (Primary)
  • Indications Bacterial infections
  • Focus Adverse reactions; Registrational
  • Sponsors Pfizer
  • Most Recent Events

    • 25 Jun 2015 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
    • 28 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Jan 2014 Planned End Date changed from 1 Dec 2013 to 1 Jan 2014.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top